Home » Topics » BioWorld Science, Dermatologic

BioWorld Science, Dermatologic
RSS

Promising interim results presented from phase IIa study of CTP-543 in patients with alopecia areata

Nov. 13, 2018

Novel RORgammat inhibitors developed by Shionogi for treating Th17-mediated autoimmune diseases

Nov. 12, 2018

Discovery and optimization of Aurora B-selective SYK inhibitors as topical agents for skin diseases

Nov. 8, 2018

Positive topline results presented from phase III program evaluating FMX-103

Nov. 8, 2018

AK-111 begins first-in-human study in healthy subjects

Nov. 6, 2018

New fully human skin cell culture facilitates grafting

Nov. 6, 2018

Leo Pharma opens phase Ib study of LEO-134310 in chronic plaque psoriasis

Nov. 5, 2018

Clean antagonist antibody can control skin inflammation

Nov. 5, 2018

Boehringer Ingelheim initiates phase I study of BI-730460

Oct. 29, 2018

AQP9 emerges as a candidate gene for keloid development

Oct. 25, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 6, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...